These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38056709)

  • 1. Treatment with the selective PDE4B inhibitor A-33 or PDE4D inhibitor zatolmilast prevents sleep deprivation-induced deficits in spatial pattern separation.
    Zhao H; Blokland A; Prickaerts J; Havekes R; Heckman PRA
    Behav Brain Res; 2024 Feb; 459():114798. PubMed ID: 38056709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors roflumilast and vardenafil prevent sleep deprivation-induced deficits in spatial pattern separation.
    Heckman PRA; Roig Kuhn F; Raven F; Bolsius YG; Prickaerts J; Meerlo P; Havekes R
    Synapse; 2020 Jun; 74(6):e22150. PubMed ID: 32056276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roflumilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Sleep Deprivation-Induced Cognitive Dysfunction in C57BL/6J Mice.
    Bhat A; Bishir M; Pandi-Perumal SR; Chang SL; Chidambaram SB
    ACS Chem Neurosci; 2022 Jul; 13(13):1938-1947. PubMed ID: 35736514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Cognitive Dysfunction after Traumatic Brain Injury Is Improved with a Phosphodiesterase 4B Inhibitor.
    Titus DJ; Wilson NM; Freund JE; Carballosa MM; Sikah KE; Furones C; Dietrich WD; Gurney ME; Atkins CM
    J Neurosci; 2016 Jul; 36(27):7095-108. PubMed ID: 27383587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of two phosphodiesterase 4 inhibitors against lipopolysaccharide-induced neuroinflammation in mice.
    Kang DH; Ahn S; Chae JW; Song JS
    BMC Neurosci; 2023 Jul; 24(1):39. PubMed ID: 37525115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rolipram Rescues Memory Consolidation Deficits Caused by Sleep Deprivation: Implication of the cAMP/PKA and cAMP/Epac Pathways.
    Maher A; El Sayed N; Nafea H; Gad M
    CNS Neurol Disord Drug Targets; 2022; 21(7):631-639. PubMed ID: 34397335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the therapeutic index of a novel phosphodiesterase 4B-selective inhibitor over phosphodiesterase 4D in mice.
    Suzuki O; Mizukami K; Etori M; Sogawa Y; Takagi N; Tsuchida H; Morimoto K; Goto T; Yoshino T; Mikkaichi T; Hirahara K; Nakamura S; Maeda H
    J Pharmacol Sci; 2013; 123(3):219-26. PubMed ID: 24152964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep deprivation impairs cAMP signalling in the hippocampus.
    Vecsey CG; Baillie GS; Jaganath D; Havekes R; Daniels A; Wimmer M; Huang T; Brown KM; Li XY; Descalzi G; Kim SS; Chen T; Shang YZ; Zhuo M; Houslay MD; Abel T
    Nature; 2009 Oct; 461(7267):1122-5. PubMed ID: 19847264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
    Schepers M; Paes D; Tiane A; Rombaut B; Piccart E; van Veggel L; Gervois P; Wolfs E; Lambrichts I; Brullo C; Bruno O; Fedele E; Ricciarelli R; Ffrench-Constant C; Bechler ME; van Schaik P; Baron W; Lefevere E; Wasner K; Grünewald A; Verfaillie C; Baeten P; Broux B; Wieringa P; Hellings N; Prickaerts J; Vanmierlo T
    Brain Behav Immun; 2023 Mar; 109():1-22. PubMed ID: 36584795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep deprivation causes memory deficits by negatively impacting neuronal connectivity in hippocampal area CA1.
    Havekes R; Park AJ; Tudor JC; Luczak VG; Hansen RT; Ferri SL; Bruinenberg VM; Poplawski SG; Day JP; Aton SJ; Radwańska K; Meerlo P; Houslay MD; Baillie GS; Abel T
    Elife; 2016 Aug; 5():. PubMed ID: 27549340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transiently increasing cAMP levels selectively in hippocampal excitatory neurons during sleep deprivation prevents memory deficits caused by sleep loss.
    Havekes R; Bruinenberg VM; Tudor JC; Ferri SL; Baumann A; Meerlo P; Abel T
    J Neurosci; 2014 Nov; 34(47):15715-21. PubMed ID: 25411499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D.
    Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J
    Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
    Xu M; Yu X; Meng X; Huang S; Zhang Y; Zhang A; Jia Z
    Am J Physiol Renal Physiol; 2020 Mar; 318(3):F576-F588. PubMed ID: 31961716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
    Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
    J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice.
    Zhang FF; Wang H; Zhou YM; Yu HY; Zhang M; Du X; Wang D; Zhang F; Xu Y; Zhang JG; Zhang HT
    CNS Neurosci Ther; 2022 May; 28(5):749-760. PubMed ID: 35156776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast.
    Tao X; He H; Peng J; Xu R; Fu J; Hu Y; Li L; Yang X; Feng X; Zhang C; Zhang L; Yu X; Shen A; Huang K; Fu Q
    Pharmacol Res; 2022 Jan; 175():106004. PubMed ID: 34826603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.
    Singh P; Mishra M; Agarwal S; Sau S; Iyer AK; Kashaw SK
    Curr Comput Aided Drug Des; 2019; 15(4):334-366. PubMed ID: 30394213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
    Guariento S; Bruno O; Fossa P; Cichero E
    Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.